Yan Shiqing, Sloane Bonnie F
Department of Pharmacology, Wayne State University School of Medicine, 540 E. Canfield, Detroit, MI 48201, USA.
Biol Chem. 2003 Jun;384(6):845-54. doi: 10.1515/BC.2003.095.
Cathepsin B is a papain-family cysteine protease that is normally located in lysosomes, where it is involved in the turnover of proteins and plays various roles in maintaining the normal metabolism of cells. This protease has been implicated in pathological conditions, e.g., tumor progression and arthritis. In disease conditions, increases in the expression of cathepsin B occur at both the gene and protein levels. At the gene level, the altered expression results from gene amplification, elevated transcription, use of alternative promoters and alternative splicing. These molecular changes lead to increased cathepsin B protein levels and in turn redistribution, secretion and increased activity. Here we focus on the molecular regulation of cathepsin B and attendant implications for tumor progression and arthritis. The potential of cathepsin B as a therapeutic target is also discussed.
组织蛋白酶B是一种木瓜蛋白酶家族的半胱氨酸蛋白酶,通常位于溶酶体中,参与蛋白质的周转,并在维持细胞正常代谢中发挥多种作用。这种蛋白酶与病理状况有关,例如肿瘤进展和关节炎。在疾病状态下,组织蛋白酶B的表达在基因和蛋白质水平上均会增加。在基因水平上,表达改变是由基因扩增、转录升高、使用替代启动子和可变剪接引起的。这些分子变化导致组织蛋白酶B蛋白水平升高,进而导致重新分布、分泌和活性增加。在这里,我们重点关注组织蛋白酶B的分子调控及其对肿瘤进展和关节炎的影响。还讨论了组织蛋白酶B作为治疗靶点的潜力。